Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,449 | -10,532 | -2,532 | -7,537 | -17,340 |
| Depreciation Amortization | 3 | 419 | 233 | 238 | 259 |
| Accounts receivable | 766 | -605 | 657 | -982 | 111 |
| Other Working Capital | 3,113 | -223 | -664 | -2,211 | 3,668 |
| Other Operating Activity | -8,330 | 6,986 | -5,303 | 3,632 | 11,054 |
| Operating Cash Flow | $1 | $-3,955 | $-7,609 | $-6,860 | $-2,248 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -13 | -40 | -7 | -2 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 1 |
| Investing Cash Flow | $-2 | $-13 | $-40 | $-7 | $-1 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -2,750 | -2,750 | N/A | N/A |
| Common Stock Issued | 29 | N/A | N/A | 13,293 | 179 |
| Other Financing Activity | 0 | 4,654 | 5,826 | 0 | 0 |
| Financing Cash Flow | $29 | $1,904 | $3,076 | $13,293 | $179 |
| Beginning Cash Position | 396 | 2,460 | 7,033 | 607 | 2,677 |
| End Cash Position | 424 | 396 | 2,460 | 7,033 | 607 |
| Net Cash Flow | $28 | $-2,064 | $-4,573 | $6,426 | $-2,070 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1 | -3,955 | -7,609 | -6,860 | -2,248 |
| Capital Expenditure | -2 | -13 | -40 | -7 | -2 |
| Free Cash Flow | -1 | -3,968 | -7,649 | -6,867 | -2,250 |